Surrey Heartlands

Joint Formulary & PAD

Warfarin sodium - Atrial fibrillation

You are here : Home > Formulary Search > Warfarin sodium - Atrial fibrillation

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines BNF SPC
NICE
Restrictions / Comments :

Documentation

Guidelines (Local)
Atrial Fibrillation Management - Secondary Care Pathway - February 2018
Guidelines (Local)
Atrial Fibrillation Management -Primary Care Pathway - February 2018
Guidelines (Local)
Anticoagulation Monitoring - Primary Care service Guidelines - Jan 2018
Guidelines (Local)
Dual antiplatelet-anticoagulant therapy - Aide memoire for managing Hospital Requests
Guidelines (Local)
Oral Anticoagulant selection tool in Atrial Fibrillation - Jun 24.pdf
Guidelines (National)
NICE Clinical guideline [CG180] : Atrial fibrillation: management
Evidence Review
Atrial Fibrillation Management - Evidence Review - September 2014
Patient resource
Starting Anticoagulation video for patients - Wessex AHSN
Patient resource
Atrial Fibrillation - NICE Patient Decision Aid - Jun 2014
Information
Contraindications to Anticoagulants and Antiplatelets - NHS Surrey Guidance Jul11
Information
ORBIT Bleed risk scoring tool for anticoagulation in AF - March 2022.pdf
Information
Calculating Creatinine Clearance for DOACs - April 2020

PAD Profile

ChemicalSubstance :
Warfarin sodium
Indication :
Atrial fibrillation
Group Name :
Keywords :
SPAF, stroke prevention in AF, anticoagulation, vitamin K antagonist, anticoagulant cards, anticoagulant alert cards,mdCalc, Cockcroft-Gault, creatinine clearance, bleed, risk, ORBIT
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Atrial fibrillation
Supporting Documents :
12

Other Indications

Below are listed other indications that Warfarin sodium is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Atrial fibrillation.

Committee Recommendations (4)

07 Feb 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee agreed the updated Surrey Heartlands Oral Anticoagulant selection tool in Atrial Fibrillation.

Apixaban is now the recommended 1st-line DOAC in accordance with the updated NHSE Commissioning Recommendations.

Apixaban is available generically and is the most cost-effective DOAC.

Refer to the Oral Anticoagulation Selection Tool for full guidance.

02 Mar 22 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands ICS Area Prescribing Committee have agreed the use of an ORBIT-bleed risk scoring tool when considering or reviewing anticoagulant treatment in Atrial Fibrillation (AF).

04 Mar 20 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

The Surrey & North West Sussex Area Prescribing Committee have agreed the updated guidance on calculating creatinine clearance for DOACs. 

01 Jun 16 - Surrey Medicines Commissioners Group
Surrey Medicines Commissioning Group recommend that patients prescribed all types of anticoagulants (warfarin and NOACs) should be given an anticoagulant alert card to carry with them. For patients taking NOACs, the card should be annotated on the reverse in the “Therapeutic range (INR)” box with the words “not applicable” or “not required for this drug”.
The cards are available for practices to order through usual NHS stationery supply routes.
See an example of the Anticoagulant Alert Card in the document below